Processa Pharmaceuticals, Inc. Diluted Shares Outstanding (Weighted Average)
Processa Pharmaceuticals, Inc. (PCSA) reported Diluted Shares Outstanding (Weighted Average) of 2.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.75M shares, a 337.46% increase year-over-year.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 2.62M shares, a 601.44% increase year-over-year.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -69.28M shares.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 47.53M shares, a 1350.72% increase year-over-year.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.31M shares, a 969.33% increase from fiscal 2024.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 122.44K shares, a 90.66% decline from fiscal 2023.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.31M shares, a 62.83% increase from fiscal 2022.
- Processa Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 805.48K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.75M shares 10-Q · filed 2026-08-14 | 2.69M shares 10-Q · filed 2026-08-14 | -21.30M shares derived: average of 3 quarters · filed 2026-08-14 | -4.10M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 2.62M shares 10-Q · filed 2026-05-07 | -33.33M shares derived: average of 2 quarters · filed 2026-05-07 | -6.38M shares derived: average of 3 quarters · filed 2026-05-07 | -4.63M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -69.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -10.88M shares derived: average of 2 quarters · filed 2026-03-18 | -7.04M shares derived: average of 3 quarters · filed 2026-08-14 | 1.31M shares 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 47.53M shares 10-Q · filed 2025-11-06 | 24.08M shares derived: average of 2 quarters · filed 2026-08-14 | 24.84M shares 10-Q · filed 2025-11-06 | 10.07M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 628.80K shares 10-Q · filed 2026-08-14 | 15.57M shares 10-Q · filed 2025-08-07 | 502.08K shares 10-Q · filed 2026-08-14 | 12.40M shares 10-Q · filed 2025-08-07 | -2.41M shares derived: average of 3 quarters · filed 2026-08-14 | -990.33K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 373.97K shares 10-Q · filed 2026-05-07 | 9.53M shares 10-Q · filed 2025-05-08 | -3.93M shares derived: average of 2 quarters · filed 2026-05-07 | -1.53M shares derived: average of 3 quarters · filed 2026-05-07 | -401.71K shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -8.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -2.48M shares derived: average of 2 quarters · filed 2026-03-18 | -660.26K shares derived: average of 3 quarters · filed 2026-03-18 | 122.44K shares 10-K · filed 2026-03-18 | 3.06M shares 10-K · filed 2025-03-20 | |||
| 2024-09-30 | 3.28M shares 10-Q · filed 2025-11-06 | 3.13M shares derived: average of 2 quarters · filed 2025-11-06 | 2.91M shares 10-Q · filed 2025-11-06 | 2.53M shares derived: average of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | 2.98M shares 10-Q · filed 2025-08-07 | 2.72M shares 10-Q · filed 2025-08-07 | 2.29M shares derived: average of 3 quarters · filed 2025-08-07 | 2.05M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 2.47M shares 10-Q · filed 2025-05-08 | 1.94M shares derived: average of 2 quarters · filed 2025-05-08 | 1.74M shares derived: average of 3 quarters · filed 2025-05-08 | 1.64M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 1.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.38M shares derived: average of 2 quarters · filed 2025-03-20 | 1.37M shares derived: average of 3 quarters · filed 2025-03-20 | 1.31M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 1.35M shares 10-Q · filed 2024-10-30 | 27.00M shares 10-Q · filed 2023-11-13 | 1.35M shares derived: average of 2 quarters · filed 2024-10-30 | 1.28M shares 10-Q · filed 2024-10-30 | 25.59M shares 10-Q · filed 2023-11-13 | -10.23M shares derived: average of 4 quarters · filed 2024-10-30 | ||
| 2023-06-30 | 1.35M shares 10-Q · filed 2024-08-13 | 26.94M shares 10-Q · filed 2023-08-10 | 1.24M shares 10-Q · filed 2024-08-13 | 24.86M shares 10-Q · filed 2023-08-10 | -14.09M shares derived: average of 3 quarters · filed 2024-08-13 | -6.52M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 1.14M shares 10-Q · filed 2024-05-10 | -21.81M shares derived: average of 2 quarters · filed 2024-05-10 | -9.14M shares derived: average of 3 quarters · filed 2024-05-10 | -2.87M shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | -44.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -14.28M shares derived: average of 2 quarters · filed 2024-03-29 | -4.20M shares derived: average of 3 quarters · filed 2024-03-29 | 805.48K shares 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | 16.20M shares 10-Q · filed 2023-11-13 | 16.07M shares derived: average of 2 quarters · filed 2023-11-13 | 15.99M shares 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | 15.94M shares 10-Q · filed 2023-08-10 | 15.89M shares 10-Q · filed 2023-08-10 | ||||||
| 2017-12-31 | 32.60M shares 10-K · filed 2018-04-16 | |||||||
| 2016-12-31 | 29.32M shares 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |